The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled for 08–10 October 2026 in Tokyo, Japan, with a hybrid participation option, organized by Magnus Group.
This international conference brings together professionals and experts working across clinical oncology, cancer research, translational medicine, healthcare, and related scientific fields.
🌍 Be Part of ICTO 2026
The conference offers an opportunity for participants to present their research, exchange scientific knowledge, establish professional connections, and discuss emerging developments in oncology.
📅 Event Information
Conference: 9th Edition of the International Conference on Clinical & Translational Oncology
Date: 08–10 October 2026
Venue: Tokyo, Japan
Event Format: Hybrid Event
🔬 Who Can Participate?
ICTO 2026 welcomes participation from:
- Oncologists
- Cancer researchers
- Clinicians
- Medical professionals
- Academicians
- Healthcare professionals
- Translational medicine researchers
- Pharmaceutical and biotechnology professionals
- Students and early-career researchers
🎤 Present Your Research
Researchers and professionals can take part by submitting their abstracts for consideration and sharing their scientific work with an international audience.
👉 Submit your abstract: ICTO 2026 Abstract Submission
🌐 Register Now
Whether you plan to attend in person in Tokyo, Japan, or participate online, ICTO 2026 provides an opportunity to connect with the international oncology community.
👉 Register here: https://magnusconferences.com/cancer-oncology/register
For additional conference information, visit: https://magnusconferences.com/cancer-oncology/
📩 Contact: cancer@magnusconference.com
🎗️ Save the Date
08–10 October 2026 | Tokyo, Japan | Hybrid Event
Register now and join the global community advancing clinical and translational oncology.
#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerConference #OncologyConference #CancerResearchConference #MedicalResearch #ClinicalResearch #HealthcareInnovation #CancerCare #Tokyo #Japan #HybridConference #MagnusGroup
No comments:
Post a Comment